PQ 2001
2001. Deputy David Cullinane asked the Minister for Health further to Parliamentary Question No. 612 of 5 July 2022, the reason that the HSE does not have a mechanism to detail the costs associated with the extension in use of certain drugs to new indications, new uses by way of comparison of diagnostic information data with its reimbursement systems. [41618/22]
Introduced
26 July 2022
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
26 July 2022
Summary
2001. Deputy David Cullinane asked the Minister for Health further to Parliamentary Question No. 612 of 5 July 2022, the reason that the HSE does not have a mechanism to detail the costs associated with the extension in use of certain drugs to new indications, new uses by way of comparison of diagnostic information data with its reimbursement systems. [41618/22]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 26 July 2022
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2022-07-26/2001/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2022-07-26/pq_2001